Highest development stage: Phase 3

Development status: Inactive

Mechanism of Action/Target pathogen: Binds to minor groove of DNA; activity against parasites and also Mycobacterium tuberculosis.

Reason dropped: Was in clinical trials but not for bacterial infections. Phase I trials demonstrated safety in humans